ArticleAbdominal radiology (New York)2025
CT and MRI characteristics of inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen: a report of 11 patients with pathological correlation.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Splenic inflammatory pseudotumor-like follicular dendritic cell sarcoma: a case report with imaging features and literature review.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to outline the computed tomography (CT) and magnetic resonance imaging (MRI) characteristics of inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS) in the spleen and to link these imaging features with histopathological findings. MATERIALS AND
methodsA retrospective analysis was conducted on 11 patients (3 males, 8 females; mean age, 63.3 ± 9.66 years; age range, 44-76 years; median age, 62 years) with histopathologically confirmed inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen (IPT-like FDCS). The study encompassed a comprehensive review of initial clinical manifestations, macroscopic pathological alterations, along with histopathological and corresponding immunohistochemical findings. CT (n = 10) and MRI (n = 8) characteristics were meticulously assessed by two experienced radiologists, who evaluated parameters including lesion number, size, shape, margin definition, capsular integrity, attenuation, signal intensity, presence of hemosiderin deposition, and patterns of contrast enhancement.
resultsIn this study, all eleven patients (11/11; 100%) presented with solitary inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS). The majority of these cases were incidentally detected during routine physical examinations, while one case was revealed through abdominal CT following a decline in platelet count post-radiation and chemotherapy for prostate cancer. The splenic lesions were predominantly oval in shape (10/11; 91%), with a single case exhibiting a lobulated appearance (1/11; 9%). The largest lesion diameter was 18 cm, with diameters ranging from 3.3 to 18 cm, averaged 6.5 cm, and a median diameter of 5.0 cm. On plain CT images, the lesions were primarily observed as hypodense with poorly defined margins. On contrast-enhanced CT, all lesions (10/10; 100%) promptly became sharply demarcated in the arterial phase, encircled by a perceptible, relatively hypodense capsule-like rim. On T2-weighted MRI, all lesions (8/8; 100%) displayed a characteristic rim-like low-intensity capsular margin. These low-signal/density capsular margins were pathologically confirmed to be capsules containing fibrous components.
conclusionsIPT-like FDCS is very rare but has characteristic imaging features that correlate with its pathology.
Indexed as
Identifiers
39661077What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.